FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367296089> ?p ?o ?g. }

• W4367296089 abstract "<h3>Objective:</h3> We aim to assess the effect of anti-epileptic drug, “AED”, prophylaxis for early or late post traumatic seizures, targeting the pediatric age population with traumatic brain injury, “TBI”. <h3>Background:</h3> Traumatic brain injury is one of the known causes of seizures. There have been several studies investigating the benefit of AED prophylaxis for early and late post traumatic seizures. However, not many discussed that for the pediatric population, exclusively. <h3>Design/Methods:</h3> We systematically searched for studies reporting the incidence of posttraumatic seizures in pediatric patients who suffered from TBI and received AEDs prophylactically following their TBI incident. Studies that included adult patients, adult and pediatric patients but did not report results for the pediatric population separately and patients who did not suffer from a TBI, were excluded. Studies that did not indicate the use of antiepileptic drugs prophylactically following TBI were excluded. <h3>Results:</h3> A total of 10 studies were included involving 4621 post traumatic brain injury patients of the pediatric age population (<18). The majority of the studies included Levetiracetam or Phenytoin as AED prophylaxis for post traumatic seizures. Five studies assessed the effect of prophylaxis on early seizures, 4 on late seizures, and 1 on any seizure. The mean incidence of early post traumatic seizures with AED prophylaxis was 8%. Moreover, one study revealed no benefit of AED prophylaxis for early post traumatic seizures. Regarding late post traumatic seizures, the average incidence with AED prophylaxis was 7.1%. However, no studies demonstrated a benefit of AED prophylaxis. Additionally, one study showed a lower incidence of post traumatic seizures with Levetiracetam prophylaxis (37%) than Phenytoin (41%). <h3>Conclusions:</h3> In conclusion, AED prophylaxis seems to be effective against early post traumatic seizures for the pediatric population, with Levetiracetam possibly being more effective. Also, there is no observed benefit for late post traumatic seizures. <b>Disclosure:</b> Dr. Al Jayyousi has nothing to disclose. Dr. Hazaimeh has nothing to disclose. Mr. Freitekh has nothing to disclose. Ms. Sawan has nothing to disclose. Dr. Jbarah has nothing to disclose." @default.
• W4367296089 created "2023-04-29" @default.
• W4367296089 creator A5017458620 @default.
• W4367296089 creator A5032686788 @default.
• W4367296089 creator A5075973298 @default.
• W4367296089 creator A5076378334 @default.
• W4367296089 creator A5082787452 @default.
• W4367296089 creator A5087138002 @default.
• W4367296089 date "2023-04-25" @default.
• W4367296089 modified "2023-09-30" @default.
• W4367296089 title "Anti-epileptic Prophylaxis for Early or Late Post-traumatic Seizures in Children with Traumatic Brain Injury: A Systematic Review (P13-1.009)" @default.
• W4367296089 doi "https://doi.org/10.1212/wnl.0000000000204103" @default.
• W4367296089 hasPublicationYear "2023" @default.
• W4367296089 type Work @default.
• W4367296089 citedByCount "0" @default.
• W4367296089 crossrefType "proceedings-article" @default.
• W4367296089 hasAuthorship W4367296089A5017458620 @default.
• W4367296089 hasAuthorship W4367296089A5032686788 @default.
• W4367296089 hasAuthorship W4367296089A5075973298 @default.
• W4367296089 hasAuthorship W4367296089A5076378334 @default.
• W4367296089 hasAuthorship W4367296089A5082787452 @default.
• W4367296089 hasAuthorship W4367296089A5087138002 @default.
• W4367296089 hasConcept C118552586 @default.
• W4367296089 hasConcept C120665830 @default.
• W4367296089 hasConcept C121332964 @default.
• W4367296089 hasConcept C187212893 @default.
• W4367296089 hasConcept C2777332695 @default.
• W4367296089 hasConcept C2778186239 @default.
• W4367296089 hasConcept C2778337148 @default.
• W4367296089 hasConcept C2781017439 @default.
• W4367296089 hasConcept C2908647359 @default.
• W4367296089 hasConcept C42219234 @default.
• W4367296089 hasConcept C61511704 @default.
• W4367296089 hasConcept C71924100 @default.
• W4367296089 hasConcept C99454951 @default.
• W4367296089 hasConceptScore W4367296089C118552586 @default.
• W4367296089 hasConceptScore W4367296089C120665830 @default.
• W4367296089 hasConceptScore W4367296089C121332964 @default.
• W4367296089 hasConceptScore W4367296089C187212893 @default.
• W4367296089 hasConceptScore W4367296089C2777332695 @default.
• W4367296089 hasConceptScore W4367296089C2778186239 @default.
• W4367296089 hasConceptScore W4367296089C2778337148 @default.
• W4367296089 hasConceptScore W4367296089C2781017439 @default.
• W4367296089 hasConceptScore W4367296089C2908647359 @default.
• W4367296089 hasConceptScore W4367296089C42219234 @default.
• W4367296089 hasConceptScore W4367296089C61511704 @default.
• W4367296089 hasConceptScore W4367296089C71924100 @default.
• W4367296089 hasConceptScore W4367296089C99454951 @default.
• W4367296089 hasLocation W43672960891 @default.
• W4367296089 hasOpenAccess W4367296089 @default.
• W4367296089 hasPrimaryLocation W43672960891 @default.
• W4367296089 hasRelatedWork W2015141254 @default.
• W4367296089 hasRelatedWork W2274136932 @default.
• W4367296089 hasRelatedWork W2434857734 @default.
• W4367296089 hasRelatedWork W2562151887 @default.
• W4367296089 hasRelatedWork W2728781949 @default.
• W4367296089 hasRelatedWork W2910696677 @default.
• W4367296089 hasRelatedWork W2955536017 @default.
• W4367296089 hasRelatedWork W2975262742 @default.
• W4367296089 hasRelatedWork W3216748380 @default.
• W4367296089 hasRelatedWork W2607623777 @default.
• W4367296089 isParatext "false" @default.
• W4367296089 isRetracted "false" @default.
• W4367296089 workType "article" @default.